Paul Metzinger - Bio Lab President CEO, Acting CFO, Director
CEO
Mr. Metzinger was the President and Chief Executive Officer of Vyta Corporationration from February 26, 1998 to May 6, 1998 and has served in that same capacity from December 1, 1998 to present. In addition, Mr. Metzinger was serving as acting Chief Financial Officer since February of 2007. He was a director since February 26, 1998. He has served as a Manager and Vice President of BioAgra since August 15, 2005. He served as the General Manager of NanoPierce Card from January 2000 to June 2003. Prior to becoming a director, Mr. Metzinger practiced securities law in Denver, Colorado for over 32 years since 2007.
Age | 73 |
Tenure | 17 years |
Phone | 855-413-7030 |
Web | https://www.limitlessx.com |
Bio Lab Management Efficiency
The company has return on total asset (ROA) of (50.94) % which means that it has lost $50.94 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (173.55) %, meaning that it created substantial loss on money invested by shareholders. Bio Lab's management efficiency ratios could be used to measure how well Bio Lab manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 392.05 K in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Bio Lab Naturals has a current ratio of 1.01, suggesting that it is in a questionable position to pay out its financial obligations when due. Debt can assist Bio Lab until it has trouble settling it off, either with new capital or with free cash flow. So, Bio Lab's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bio Lab Naturals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bio to invest in growth at high rates of return. When we think about Bio Lab's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | CEO Age | ||
Alvaro Garcia | Compania Cervecerias Unidas | N/A | |
Bernardo Paiva | Ambev SA ADR | 45 | |
Hugo Zalazar | Compania Cervecerias Unidas | N/A | |
Stephen Arcos | Compania Cervecerias Unidas | N/A | |
Francisco Dominguez | Compania Cervecerias Unidas | 59 | |
Claudio Melendez | Compania Cervecerias Unidas | N/A | |
Ronald Bernstein | Vector Group | 67 | |
Matias Subercaseaux | Compania Cervecerias Unidas | N/A | |
Fernando Mora | Compania Cervecerias Unidas | N/A | |
Ivan Menezes | Diageo PLC ADR | 65 | |
Matias Bebin | Compania Cervecerias Unidas | N/A | |
Alvaro Roman | Compania Cervecerias Unidas | N/A | |
Fernando Sacchi | Compania Cervecerias Unidas | 59 | |
Howard Lorber | Vector Group | 75 | |
Pedro Aguado | Compania Cervecerias Unidas | 50 | |
Domingo Manterola | Compania Cervecerias Unidas | 39 | |
Jean Neto | Ambev SA ADR | 50 | |
Jose Nasrallah | Compania Cervecerias Unidas | 58 | |
Anand Kripalu | Diageo PLC ADR | 59 | |
Carlos Diaz | Compania Cervecerias Unidas | N/A | |
Francisco Mackenna | Compania Cervecerias Unidas | 57 |
Management Performance
Return On Equity | -173.55 | |||
Return On Asset | -50.94 |
Bio Lab Naturals Leadership Team
Elected by the shareholders, the Bio Lab's board of directors comprises two types of representatives: Bio Lab inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bio. The board's role is to monitor Bio Lab's management team and ensure that shareholders' interests are well served. Bio Lab's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bio Lab's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Hoback, Director | ||
Herbert Neuhaus, Executive Vice President - Marketing and Technology, Director | ||
Robert Shaw, Director | ||
Paul Metzinger, President CEO, Acting CFO, Director |
Bio Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Bio Lab a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -173.55 | |||
Return On Asset | -50.94 | |||
Current Valuation | 30.05 M | |||
Shares Owned By Insiders | 51.17 % | |||
Price To Earning | 0.07 X | |||
Price To Book | 12.95 X | |||
Price To Sales | 1.35 X | |||
Revenue | 339.18 K | |||
Gross Profit | 87.55 K | |||
EBITDA | (159.8 K) |
Pair Trading with Bio Lab
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Lab position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Lab will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Paychex could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Paychex when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Paychex - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Paychex to buy it.
The correlation of Paychex is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Paychex moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Paychex moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Paychex can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Bio Lab Naturals information on this page should be used as a complementary analysis to other Bio Lab's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Bio OTC Stock
If you are still planning to invest in Bio Lab Naturals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bio Lab's history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Global Correlations Find global opportunities by holding instruments from different markets |